Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Current Opinion in Investigational Drugs (London, England : 2000)|December 3, 2004
COLAL-PRED AlizymeStephen B Hanauer, Miles SparrowCurrent Opinion in Gastroenterology|February 11, 2005
Therapy of ulcerative colitisStephen B Hanauer, Miles SparrowNutrition (Burbank, Los Angeles County, Calif.)|May 26, 2020
Utility of bioimpedance methods for the assessment of fat-free mass in adult outpatients with inflammatory bowel diseaseJessica Wood, Leigh Ward, Miles Sparrow, et al.Inflammatory Bowel Diseases|February 26, 2011
Use of thiopurine testing in the management of inflammatory bowel diseases in clinical practice: a worldwide survey of expertsXavier Roblin, Abderrahim Oussalah, Jean-Baptiste Chevaux, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 12, 2018
Low-dose thiopurine with allopurinol co-therapy overcomes thiopurine intolerance and allows thiopurine continuation in inflammatory bowel diseaseAbhinav Vasudevan, Lauren Beswick, Antony B Friedman, et al.Journal of Inflammation (London, England)|October 23, 2014
Comparison of inflammation, arterial stiffness and traditional cardiovascular risk factors between rheumatoid arthritis and inflammatory bowel diseaseFenling Fan, Abby Galvin, Lu Fang, et al.Pharmacogenomics|July 17, 2009
Thiopurine methyltransferase and thiopurine metabolite testing in patients with inflammatory bowel disease who are taking thiopurine drugsLeslie J Sheffield, Peter Irving, Arun Gupta, et al.Inflammatory Bowel Diseases|February 8, 2024
Thrombocytosis and Transaminitis in Infants Born to Women With Inflammatory Bowel Disease Is Associated With Exposure to Maternal Inflammation In UteroRalley Prentice, Emma Flanagan, Emily Wright, et al.Journal of Crohn'S & Colitis|February 17, 2024
Thiopurine Metabolite Shunting in Late Pregnancy Increases the Risk of Intrahepatic Cholestasis of Pregnancy in Women With Inflammatory Bowel Disease, and Can be Managed With Split DosingRalley Prentice, Emma Flanagan, Emily Wright, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 5, 2015
Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti-Tumor Necrosis Factor Therapy for Crohn's Disease: A Meta-analysis of Placebo-controlled TrialsJennifer L Jones, Gilaad G Kaplan, Laurent Peyrin-Biroulet, et al.Pageof 2